SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:lup.lub.lu.se:b966b8b4-076e-46d7-8f56-7c19f2415324"
 

Sökning: id:"swepub:oai:lup.lub.lu.se:b966b8b4-076e-46d7-8f56-7c19f2415324" > FGFR3 mutation incr...

FGFR3 mutation increases bladder tumourigenesis by suppressing acute inflammation

Foth, Mona (författare)
Beatson Institute for Cancer Research,University of Glasgow
Ismail, Nur Faezah Binti (författare)
University of Glasgow
Kung, Jeng Sum Charmaine (författare)
University of Glasgow
visa fler...
Tomlinson, Darren (författare)
St James's University Hospital
Knowles, Margaret A. (författare)
St James's University Hospital
Eriksson, Pontus (författare)
Lund University,Lunds universitet,Genomiska analyser av urinblåscancer,Forskargrupper vid Lunds universitet,Urothelial Cancer Genomics,Lund University Research Groups
Sjödahl, Gottfrid (författare)
Lund University,Lunds universitet,Genomiska analyser av urinblåscancer,Forskargrupper vid Lunds universitet,Urothelial Cancer Genomics,Lund University Research Groups
Salmond, Jonathan M. (författare)
Queen Elizabeth University Hospital
Sansom, Owen J. (författare)
Beatson Institute for Cancer Research,University of Glasgow
Iwata, Tomoko (författare)
University of Glasgow
visa färre...
 (creator_code:org_t)
2018-09-19
2018
Engelska 13 s.
Ingår i: Journal of Pathology. - : Wiley. - 0022-3417. ; 246:3, s. 331-343
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Recent studies of muscle-invasive bladder cancer show that FGFR3 mutations are generally found in a luminal papillary tumour subtype that is characterised by better survival than other molecular subtypes. To better understand the role of FGFR3 in invasive bladder cancer, we examined the process of tumour development induced by the tobacco carcinogen OH-BBN in genetically engineered models that express mutationally activated FGFR3 S249C or FGFR3 K644E in the urothelium. Both occurrence and progression of OH-BBN-driven tumours were increased in the presence of an S249C mutation compared to wild-type control mice. Interestingly, at an early tumour initiation stage, the acute inflammatory response in OH-BBN-treated bladders was suppressed in the presence of an S249C mutation. However, at later stages of tumour progression, increased inflammation was observed in S249C tumours, long after the carcinogen administration had ceased. Early-phase neutrophil depletion using an anti-Ly6G monoclonal antibody resulted in an increased neutrophil-to-lymphocyte ratio at later stages of pathogenesis, indicative of enhanced tumour pathogenesis, which supports the hypothesis that suppression of acute inflammation could play a causative role. Statistical analyses of correlation showed that while initial bladder phenotypes in morphology and inflammation were FGFR3-dependent, increased levels of inflammation were associated with tumour progression at the later stage. This study provides a novel insight into the tumour-promoting effect of FGFR3 mutations via regulation of inflammation at the pre-tumour stage in the bladder.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Medicinsk genetik (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Medical Genetics (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)

Nyckelord

cancer immunology
comparative pathology
fibroblast growth factors
inflammation
neutrophils
transgenic mouse model
transitional cell carcinoma

Publikations- och innehållstyp

art (ämneskategori)
ref (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy